Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
IRELAND – AstraZeneca has announced that its rare disease group Alexion will invest €65 million (US$68.7M) to scale up its biologics manufacturing capacity and expand R&D efforts at its sites…
Read More
UNITED KINGDOM – AstraZeneca and China-based Amoy Diagnostics (AmoyDx) have signed a master collaboration agreement for multiple companion diagnostics programs in China, the EU, and Japan. The agreement allows both…
Read More
GHANA – Ghana has received 309,600 doses of the AstraZeneca COVID-19 vaccine donated by the Japanese Government to support the ongoing mass COVID-19 vaccination exercise. The Deputy Minister of Health…
Read More
NETHERLANDS – The European Union’s drug watchdog has recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other…
Read More
GHANA – AstraZeneca has announced a partnership with the Circular Bioeconomy Alliance (CBA) and local partners at the Global Forest Summit to establish the first ‘Living Lab’ by planting over…
Read More
UNITED KINGDOM – According to a company press release, AstraZeneca invested approximately US$33 million in UK-based digital health startup Huma Therapeutics. As part of the agreement, Huma will acquire AstraZeneca’s…
Read More
UNITED KINGDOM –AstraZeneca has announced the launch of a global R&D Postdoctoral Challenge to help accelerate ideas that will transform the treatment of some of the world’s most complex diseases.…
Read More
UNITED KINGDOM –AstraZeneca’s Alexion will pay US$775 million to Roche’s subsidiary, Chugai Pharmaceutical to resolve all patent disputes related to the C5 inhibitor Ultomiris (ravulizumab), the two companies have said.…
Read More
UNITED KINGDOM – AstraZeneca (AZ) has announced a new Ovarian Cancer Commitment (OCC) initiative aimed at improving survival and quality of life for women diagnosed with the disease. Fewer than…
Read More
USA – Merck & Co. has halted a Phase 3 trial testing a combination of two widely used cancer drugs, Keytruda and Lynparza, in patients with advanced prostate tumors due…
Read More